Evidence map›Paper›PMID 40807412›Full record

ArticleMolecules (Basel, Switzerland)2025

In Situ Construction of Thiazole-Linked Covalent Organic Frameworks on Cu

Zhifang Jia, Tingxia Wang, Zhaoxia Wu, Shumaila Razzaque, Zhixiang Zhao, Jiaxuan Cai, Wenao Xie, Junli Wang, Qiang Zhao, Kewei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Construction of S-Scheme BiVOMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhifang JiaDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Tingxia WangDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Zhaoxia WuDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Shumaila RazzaqueInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka Street 44/52, 01-224 Warsaw, Poland.
Zhixiang ZhaoDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Jiaxuan CaiDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Wenao XieDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Junli WangDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Qiang ZhaoDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Kewei WangDepartment of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.ORCID 0000-0002-8498-3918

Funding

National Natural Science Foundation of China 21975146National Natural Science Foundation of China 52203266Natural Science Research Project of Shanxi Province 202403021211022Shanxi Scholarship Council of China 2022-173
6 · The paper itself

Abstract

The strategic construction of heterojunctions through a simple and efficient strategy is one of the most effective means to boost the photocatalytic activity of semiconductor materials. Herein, a thiazole-linked covalent organic framework (TZ-COF) with large surface area, well-ordered pore structure, and high stability was developed. To further boost photocatalytic activity, the TZ-COF was synthesized in situ on the surface of Cu

Indexed as

Cu2Oheterojunctionphotocatalytic degradationthiazole-linked covalent organic frameworks

Identifiers

PMID40807412
PMCPMC12348375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.